1Boshkov LK, Kehon JG, Halloran PF. HLA-DR expression by platelets in acute idiopathic thrombocytopenic purpura. Br J Haenmtol, 1992, 81:552-557.
2Semple JW, Milev Y, Cosgrave D, et al. Differences in serum cytokine levels in acute and chronic antoinrnune thrombocytopenic purpura: relationship to platele! phenotype and antiplatelet T-cell reactivity. Blood,1996, 87:4245-4254.
3Erduran E, Asian Y, Aliyazicioglu Y, et al. Plasma soluble interleukin-2 receptor levels in patients with idiopathic thrombocytopenic purpura. Am J Hematol, 1998,57:219-223.
4Karakantza M, Mouzaki A, Theodoropoulou M, et al. Thl and Th2 cytokines in a patient with Evans' syndrome and profound lymphopenia. Br J Haematol,2000 110:968-970.
5Yoshimura C, Nomura S, Nagahama M, et al. Plasma-soluble Fas(APO-1, CD95) and soluble Fas ligaald in ilramme thrombocytopenic purpura. Eur J Haematol,2000, 64:219-224.
7Kuwana M, Kaburaki J, Kitasato H, et al.Immunodominant epitopes on glycoprotein Ⅱb/Ⅲa recognized by antoreactive T cells in patients with immune thrombocytopenic purpura.Blood,2001,98:130-139
8Imbach P, Kuhne T. Immune thrombocytopenic purpura ITP. Vox Sang,1998,74 Suppl 2 : 309-314.
9McMillan R. Autoantibodies and autoantigens in chronic immune thrombocytopenic purpura. Blood, 1979,54: 113-119.
10Mcmillan R. The pathogenesis of chronic immune(idiopathic) thrombocytopenic purpura. Semin Hematol, 2000, 37 Suppl 1:5-9.
